Find Paid Clinical Trials in Japan

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Japan

Top of Directory » All Locations » Japan


  • A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis

    Conditions:   Chronic Kidney Disease;   Renal Dialysis;   Renal Insufficiency
    Intervention:   Drug: ASP1585
    Sponsor:   Astellas Pharma Inc
    Not yet recruiting - verified November 2009

  • Differentiation of Aseptic From Septic Loosening by 18F-fluoride PET

    Condition:   Hip Arthroplasty
    Intervention:  
    Sponsor:   Yokohama City University Medical Center
    Completed - verified November 2009

  • Database Creation and Evaluation of Motor Function of Finger Tapping Measured by Magnetic Sensor System in Healthy Subjects

    Condition:   Healthy
    Intervention:   Device: magnetic sensor system to measure the movements of finger tapping
    Sponsor:   Hiroshima University
    Recruiting - verified November 2009

  • The Roles of Prostanoids in Patients With Sleep Apnea Syndrome

    Conditions:   Sleep Apnea;   Continuous Positive Airway Pressure
    Intervention:   Device: CPAP treatment
    Sponsor:   Kyoto University, Graduate School of Medicine
    Not yet recruiting - verified November 2009

  • A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)

    Condition:   Periodontitis
    Intervention:   Drug: Trafermin
    Sponsor:   Kaken Pharmaceutical
    Not yet recruiting - verified November 2009

  • A Study of GSK573719 in Healthy Japanese Male Subjects

    Condition:   Healthy Volunteer
    Interventions:   Drug: Placebo;   Drug: GSK573719
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Review on Minimally Invasive Skin Incision in Vanguard PS Artificial Knee Joint System

    Condition:   Gonarthrosis Patients Who Need Artificial Knee Joint Total Replacement
    Interventions:   Procedure: Incision technique;   Procedure: Incision technique
    Sponsors:   Biomet, Inc.;   Biomet Japan, Inc.
    Not yet recruiting - verified November 2009

  • MSG and Gastrointestinal Motility

    Condition:   Gastroesophageal Reflux
    Interventions:   Dietary Supplement: Monosodium glutamate;   Dietary Supplement: Sodium chloride
    Sponsor:   Gunma University
    Not yet recruiting - verified November 2009

  • Trial of 6% HES130/0.4

    Conditions:   Hypovolemia;   Hemorrhage
    Interventions:   Drug: 6% hydroxyethyl starch 130/0.4;   Drug: 6% hydroxyethyl starch 70/0.5 (Salinhes®)
    Sponsor:   Fresenius Kabi Japan
    Not yet recruiting - verified November 2009

  • Study Evaluating Multiple Ascending Doses of ATN-103 in Japanese Subjects With Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Biological: ATN-103 10 mg q4wks;   Biological: ATN-103 30 mg q4wks;   Biological: ATN-103 80 mg q4wks;   Biological: ATN-103 10 mg q8wks;   Biological: ATN-103 80 mg q8wks
    Sponsor:   Wyeth
    Recruiting - verified November 2009

  • Metabolic Syndrome and Fingertip Endothelial Dysfunction

    Condition:   Metabolic Syndrome
    Intervention:   Other: Lifestyle instruction
    Sponsor:   Kumamoto University
    Active, not recruiting - verified November 2009

  • Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

    Condition:   Retinal Vein Occlusion
    Interventions:   Drug: VEGF Trap-Eye (BAY86-5321);   Other: Sham treatment
    Sponsors:   Bayer;   Regeneron Pharmaceuticals
    Recruiting - verified November 2009

  • A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Glycopyrronium bromide;   Drug: Placebo
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • Effects of Tea Catechin Consumption on the Prophylaxis of Influenza Infection

    Condition:   Influenza Infection
    Intervention:   Dietary Supplement: tea catechin extracts
    Sponsors:   University of Shizuoka;   White Cross Nursing Home
    Recruiting - verified November 2009

  • A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder

    Condition:   Overactive Bladder
    Interventions:   Drug: KUC-7483;   Drug: Placebo;   Drug: Tolterodine
    Sponsor:   Kissei Pharmaceutical Co., Ltd.
    Recruiting - verified October 2009

  • Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder

    Condition:   Overactive Bladder
    Intervention:   Drug: KUC-7483
    Sponsor:   Kissei Pharmaceutical Co., Ltd.
    Recruiting - verified October 2009

  • A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

    Condition:   Spinocerebellar Degeneration
    Interventions:   Drug: KPS-0373;   Drug: Placebo
    Sponsor:   Kissei Pharmaceutical Co., Ltd.
    Recruiting - verified October 2009

  • Efficacy, Pharmacokinetics, Safety and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japan

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: Abatacept;   Drug: Abatacept;   Drug: Abatacept;   Drug: Placebo
    Sponsor:   Bristol-Myers Squibb
    Not yet recruiting - verified November 2009

  • A Study of LY2189265 in Japanese Patients With Type 2 Diabetes

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: LY2189265;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children

    Condition:   Influenza Infection
    Intervention:   Biological: GSK Biologicals' Pandemic influenza (H1N1) candidate vaccine (GSK2340274A)
    Sponsor:   GlaxoSmithKline
    Active, not recruiting - verified November 2009

  • Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects

    Condition:   Swine-Origin Influenza A H1N1 Virus
    Intervention:   Biological: Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine
    Sponsors:   Novartis;   Novartis Vaccines
    Active, not recruiting - verified October 2009

    • Menu
    Find Paid Clinical Trials